We have recently implicated mitochondrial mechanisms in models of neuropathic and inflammatory pain, in some of which a role of protein kinase Ce (PKCe) has also been implicated. Since mitochondria contain several proteins that are targets of PKCe, we evaluated the role of mitochondrial mechanisms in mechanical hyperalgesia induced by proinflammatory cytokines that induce PKCe-dependent nociceptor sensitization, and by a direct activator of PKCe (weRACK), in the rat. Prostaglandin E 2 (PGE 2 )-induced hyperalgesia is short lived in naïve rats, while it is prolonged in weRACK pre-treated rats, a phenomenon referred to as priming. Inhibitors of two closely related mitochondrial functions, electron transport (complexes I-V) and oxidative stress (reactive oxygen species), attenuated mechanical hyperalgesia induced by intradermal injection of weRACK. In marked contrast, in a PKCe-dependent form of mechanical hyperalgesia induced by prostaglandin E 2 (PGE 2 ), inhibitors of mitochondrial function failed to attenuate hyperalgesia. These studies support the suggestion that at least two downstream signaling pathways can mediate the hyperalgesia induced by activating PKCe. Ó
Introduction
While PKCepsilon (PKCe) a novel protein kinase C (PKC) isoform, plays an important role in primary afferent nociceptor sensitization and mechanical hyperalgesia [3, 10, 28, 40, 42, 43] mechanisms downstream of PKCe remain to be elucidated. The mitochondrion, an intracellular organelle to which PKCe can translocate [11, 15, 36] , which contains proteins phosphorylated by PKCe such as the mitochondrial respiratory chain protein, cytochrome oxidase subunit IV (COX IV) [8, 12, 32] , mitochondrial ATP-sensitive K + channel [11, 38] , and glycogen synthatase kinase-3beta [7, 29] , has recently been implicated in mechanical hyperalgesia [24, 25] . In the present study, we evaluated the hypothesis that the mitochondrion is a downstream target of PKCe mediating the induction of mechanical hyperalgesia. In previous studies [26] we have shown that administration of carrageenan or weRACK can trigger long-lasting hypersensitivity of nociceptors to inflammatory cytokines. This phenomenon ''hyperalgesic priming" was demonstrated to be PKCe dependent [21, 35] . We studied the role of four key mitochondrial mechanisms, electron transport (complexes I-V), oxidative stress (reactive oxygen species, ROS), caspase signaling, and intracellular calcium mobilization [6, 14, 30] , in mechanical hyperalgesia induced by inflammatory mediator G-protein-coupled receptors that produce PKCe-dependent hyperalgesia [19, 31] and by a more generalized activator of PKCe by pseudo-receptor for activated C kinase (weR-ACK), a direct activator of PKCe [13] .
Experimental procedures

Animals
Male (220-300 g) Sprague-Dawley rats (Charles River, Hollister, CA) used in these experiments were housed in the Laboratory Animal Resource Center of the University of California, San Francisco, under a 12-h light/dark cycle. All experimental protocols were approved by the University of California, San Francisco, Institutional Animal Care and Use Committee, and conformed to NIH guidelines for the care and use of experimental animals. Effort was made to limit the number of animals used and their discomfort.
Drugs: preparation and administration
The drugs used in these experiments were: rotenone (3 acetylphenyl N-(P-Tolyl) carbamate) a mitochondrial electron transport chain complex I (mETC-I) inhibitor; 3-NP (3 nitroproprionic acid), a mETC-II inhibitor; antimycin, a mETC-III inhibitor; sodium cyanide, a mETC-IV inhibitor; oligomycin, a mETC-V inhibitor; a-lipoic acid, an antioxidant, 4, 
